Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–528. https://doi.org/10.1161/CIR.0000000000000659.

Article  PubMed  Google Scholar 

Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–7. https://doi.org/10.1016/j.amjcard.2013.05.063.

Article  PubMed  Google Scholar 

Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746–51. https://doi.org/10.1093/eurheartj/eht280.

Article  PubMed  PubMed Central  Google Scholar 

Patel NJ, Deshmukh A, Pant S, et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014;129(23):2371–9. https://doi.org/10.1161/CIRCULATIONAHA.114.008201.

Article  PubMed  Google Scholar 

Wolowacz SE, Samuel M, Brennan VK, Jasso-Mosqueda JG, Van Gelder IC. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace. 2011;13(10):1375–85. https://doi.org/10.1093/europace/eur194.

Article  CAS  PubMed  Google Scholar 

Martin A, Coll-Vinent B, Suero C, et al. Benefits of rhythm control and rate control in recent-onset atrial fibrillation: the HERMES-AF study. Acad Emerg Med. 2019;26(9):1034–43. https://doi.org/10.1111/acem.13703.

Article  PubMed  Google Scholar 

Sacchetti A, Williams J, Levi S, Akula D. Impact of emergency department management of atrial fibrillation on hospital charges. West J Emerg Med. 2013;14(1):55–7. https://doi.org/10.5811/westjem.2012.1.6893.

Article  PubMed  PubMed Central  Google Scholar 

De Vos CB, Breithardt G, Camm AJ, et al. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. Am Heart J. 2012;163(5):887–93. https://doi.org/10.1016/j.ahj.2012.02.015.

Article  PubMed  Google Scholar 

Zhang YY, Qiu C, Davis PJ, et al. Predictors of progression of recently diagnosed atrial fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)-United States cohort. Am J Cardiol. 2013;112(1):79–84. https://doi.org/10.1016/j.amjcard.2013.02.056.

Article  PubMed  Google Scholar 

Vanassche T, Lauw MN, Eikelboom JW, et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J. 2015;36(5):281–7. https://doi.org/10.1093/eurheartj/ehu307.

Article  PubMed  Google Scholar 

Zhang W, Xiong Y, Yu L, et al. Meta-analysis of stroke and bleeding risk in patients with various atrial fibrillation patterns receiving oral anticoagulants. Am J Cardiol. 2019;123(6):922–8. https://doi.org/10.1016/j.amjcard.2018.11.055.

Article  CAS  PubMed  Google Scholar 

Senoo K, Lip GY, Lane DA, Buller HR, Kotecha D. Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS trial. Stroke. 2015;46(9):2523–8. https://doi.org/10.1161/STROKEAHA.115.009487.

Article  PubMed  Google Scholar 

Ganesan AN, Chew DP, Hartshorne T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591–602. https://doi.org/10.1093/eurheartj/ehw007.

Article  PubMed  Google Scholar 

Rogenstein C, Kelly AM, Mason S, et al. An international view of how recent-onset atrial fibrillation is treated in the emergency department. Acad Emerg Med. 2012;19(11):1255–60. https://doi.org/10.1111/acem.12016.

Article  PubMed  Google Scholar 

Lip GY, Gitt AK, Le Heuzey JY, et al. Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study). Am J Cardiol. 2014;113(3):480–4. https://doi.org/10.1016/j.amjcard.2013.10.036.

Article  CAS  PubMed  Google Scholar 

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612.

Article  PubMed  Google Scholar 

Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024;149(1):e1–156. https://doi.org/10.1161/CIR.0000000000001193.

Article  PubMed  Google Scholar 

Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36(12):1847–948. https://doi.org/10.1016/j.cjca.2020.09.001.

Article  PubMed  Google Scholar 

deSouza IS, Tadrous M, Sexton T, et al. Pharmacologic cardioversion of recent-onset atrial fibrillation and flutter in the emergency department: a systematic review and network meta-analysis. Ann Emerg Med. 2020;76(1):14–30. https://doi.org/10.1016/j.annemergmed.2020.01.013.

Article  PubMed  Google Scholar 

deSouza IS, Tadrous M, Sexton T, et al. Pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis. Europace. 2020;22(6):854–69. https://doi.org/10.1093/europace/euaa024.

Article  PubMed  Google Scholar 

Tsiachris D, Doundoulakis I, Pagkalidou E, et al. Pharmacologic cardioversion in patients with paroxysmal atrial fibrillation: a network meta-analysis. Cardiovasc Drugs Ther. 2021;35(2):293–308. https://doi.org/10.1007/s10557-020-07127-1.

Article  PubMed  Google Scholar 

Ibrahim OA, Belley-Cote EP, Um KJ, et al. Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials. Europace. 2021;23(8):1200–10. https://doi.org/10.1093/europace/euab014.

Article  PubMed  Google Scholar 

Orso D, Santangelo S, Guglielmo N, et al. Bayesian network meta-analysis of randomized controlled trials on the efficacy of antiarrhythmics in the pharmacological cardioversion of paroxysmal atrial fibrillation. Am J Cardiovasc Drugs. 2023;23(4):355–77. https://doi.org/10.1007/s40256-023-00586-5.

Article  CAS  PubMed  Google Scholar 

Stiell IG, Clement CM, Rowe BH, et al. Outcomes for emergency department patients with recent-onset atrial fibrillation and flutter treated in Canadian hospitals. Ann Emerg Med. 2017;69(5):562-71 e2. https://doi.org/10.1016/j.annemergmed.2016.10.013.

Article  PubMed  Google Scholar 

Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–84. https://doi.org/10.7326/M14-2385.

Article  PubMed  Google Scholar 

Shiroshita-Takeshita A, Brundel BJ, Nattel S. Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol. 2005;13(3):181–93. https://doi.org/10.1007/s10840-005-2362-y.

Article  PubMed  Google Scholar 

Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954–68. https://doi.org/10.1161/01.cir.92.7.1954.

Article  CAS  PubMed  Google Scholar 

Reisinger J, Gatterer E, Heinze G, et al. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. Am J Cardiol. 1998;81(12):1450–4. https://doi.org/10.1016/s0002-9149(98)00223-9.

Article  CAS  PubMed  Google Scholar 

Vardas PE, Kochiadakis GE. Amiodarone for the restoration of sinus rhythm in patients with atrial fibrillation. Card Electrophysiol Rev. 2003;7(3):297–9. https://doi.org/10.1023/B:CEPR.0000012400.34597.00.

Article  PubMed  Google Scholar 

Roy D, Pratt CM, Torp-Pedersen C, et al. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation. 2008;117(12):1518–25. https://doi.org/10.1161/CIRCULATIONAHA.107.723866.

Article  CAS  PubMed  Google Scholar 

deSouza IS, Allen R, Shrestha P. Reassessment of confidence in a network meta-analysis of antidysrhythmic drugs for atrial fibrillation cardioversion. Cardiovasc Drugs Ther. 2022;36(6):1249–51. https://doi.org/10.1007/s10557-022-07318-y.

Article  PubMed  Google Scholar 

Brignardello-Petersen R, Tomlinson G, Florez I, et al. Grading of recommendations assessment, development, and evaluation concept article 5: addressing intransitivity in a network meta-analysis. J Clin Epidemiol. 2023;160:151–9. https://doi.org/10.1016/j.jclinepi.2023.06.010.

Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. 2021;10(1):39. https://doi.org/10.1186/s13643-020-01542-z.

Article  PubMed  PubMed Central  Google Scholar 

Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.

Article  PubMed  Google Scholar 

Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS — a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10(4):325–37. https://doi.org/10.1023/A:1008929526011.

Article